Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
27.9M
-
Shares change
-
+7.83M
-
Total reported value, excl. options
-
$714M
-
Value change
-
+$196M
-
Put/Call ratio
-
0.24
-
Number of buys
-
72
-
Number of sells
-
-31
-
Price
-
$25.76
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q1 2018
122 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q1 2018.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.9M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.4M shares), PERCEPTIVE ADVISORS LLC (2.93M shares), Vivo Capital, LLC (2.05M shares), BlackRock Inc. (1.89M shares), ALLIANCEBERNSTEIN L.P. (1.46M shares), VHCP Management II, LLC (1.39M shares), WELLINGTON MANAGEMENT GROUP LLP (1.08M shares), JPMORGAN CHASE & CO (917K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (869K shares), and Foresite Capital Management IV, LLC (851K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.